| UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
|---|---|---|---|---|
| Q7RTP0 (NIPA1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Magnesium transporter NIPA1; Non-imprinted in Prader-Willi/Angelman syndrome region protein 1; Spastic paraplegia 6 protein; | |
| Q8NGH7 (O52L1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Olfactory receptor 52L1; Olfactory receptor OR11-50; | |
| P43235 (CATK_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Cathepsin K; Cathepsin O; Cathepsin O2; Cathepsin X; | |
| P0C617 (O5AL1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Olfactory receptor 5AL1; Olfactory receptor OR11-184; | |
| Q9Y256 (FACE2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | CAAX prenyl protease 2; Farnesylated proteins-converting enzyme 2; Prenyl protein-specific endoprotease 2; RCE1 homolog; | |
| Q15417 (CNN3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Calponin-3; Calponin, acidic isoform; | |
| Q9Y5K5 (UCHL5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ubiquitin carboxyl-terminal hydrolase isozyme L5; Ubiquitin C-terminal hydrolase UCH37; Ubiquitin thioesterase L5; | |
| Q96L58 (B3GT6_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Beta-1,3-galactosyltransferase 6; GAG GalTII; Galactosyltransferase II; Galactosylxylosylprotein 3-beta-galactosyltransferase; UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6; | |
| A6NHX0 (CAST2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Cytosolic arginine sensor for mTORC1 subunit 2; Cellular arginine sensor for mTORC1 protein 2; GATS-like protein 2; | |
| O00151 (PDLI1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | PDZ and LIM domain protein 1; C-terminal LIM domain protein 1; Elfin; LIM domain protein CLP-36; | |
| Q9H147 (TDIF1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Deoxynucleotidyltransferase terminal-interacting protein 1; Terminal deoxynucleotidyltransferase-interacting factor 1; | |
| Q5TD97 (FHL5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Four and a half LIM domains protein 5; Activator of cAMP-responsive element modulator in testis; | |
| Q8N3Z3 (GTPB8_HUMAN) | Swiss-Prot | Homo sapiens (Human) | GTP-binding protein 8; | |
| P42081 (CD86_HUMAN) | Swiss-Prot | Homo sapiens (Human) | T-lymphocyte activation antigen CD86; Activation B7-2 antigen; B70; BU63; CTLA-4 counter-receptor B7.2; FUN-1; CD86; | |
| P07951 (TPM2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Tropomyosin beta chain; Beta-tropomyosin; Tropomyosin-2; | |
| P09493 (TPM1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Tropomyosin alpha-1 chain; Alpha-tropomyosin; Tropomyosin-1; | |
| Q9UBV8 (PEF1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Peflin; PEF protein with a long N-terminal hydrophobic domain; Penta-EF hand domain-containing protein 1; | |
| Q9UHW5 (GPN3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | GPN-loop GTPase 3; ATP-binding domain 1 family member C; | |
| Q99612 (KLF6_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Krueppel-like factor 6; B-cell-derived protein 1; Core promoter element-binding protein; GC-rich sites-binding factor GBF; Proto-oncogene BCD1; Suppressor of tumorigenicity 12 protein; Transcription factor Zf9; | |
| Q5VVY1 (NTM1B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | N-terminal Xaa-Pro-Lys N-methyltransferase 2; Alpha N-terminal protein methyltransferase 1B; Methyltransferase-like protein 11B; X-Pro-Lys N-terminal protein methyltransferase 1B; | |
| Q96SI1 (KCD15_HUMAN) | Swiss-Prot | Homo sapiens (Human) | BTB/POZ domain-containing protein KCTD15; Potassium channel tetramerization domain-containing protein 15; | |
| Q6UWY2 (PRS57_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Serine protease 57; Neutrophil serine protease 4; Serine protease 1-like protein 1; | |
| Q4V9L6 (TM119_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transmembrane protein 119; Osteoblast induction factor; | |
| Q86VZ2 (WDR5B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | WD repeat-containing protein 5B; | |
| A6NMN3 (F170B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein FAM170B; Acrosome-related protein; | |
| P0C7P4 (UCRIL_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative cytochrome b-c1 complex subunit Rieske-like protein 1; Ubiquinol-cytochrome c reductase Rieske iron-sulfur subunit pseudogene 1; | |
| Q99943 (PLCA_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha; 1-acylglycerol-3-phosphate O-acyltransferase 1; Lysophosphatidic acid acyltransferase alpha; Protein G15; | |
| O75461 (E2F6_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transcription factor E2F6; | |
| P50591 (TNF10_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Tumor necrosis factor ligand superfamily member 10; Apo-2 ligand; TNF-related apoptosis-inducing ligand; CD253; | |
| A1L3X0 (ELOV7_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Very long chain fatty acid elongase 7; 3-keto acyl-CoA synthase ELOVL7; ELOVL fatty acid elongase 7; Elongation of very long chain fatty acids protein 7; Very long chain 3-ketoacyl-CoA synthase 7; Very long chain 3-oxoacyl-CoA synthase 7; | |
| Q6UXG3 (CLM9_HUMAN) | Swiss-Prot | Homo sapiens (Human) | CMRF35-like molecule 9; CD300 antigen-like family member G; Triggering receptor expressed on myeloid cells 4; CD300g; | |
| P52954 (LBX1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transcription factor LBX1; Ladybird homeobox protein homolog 1; | |
| P57052 (RBM11_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Splicing regulator RBM11; RNA-binding motif protein 11; | |
| A8MXV6 (CD15L_HUMAN) | Swiss-Prot | Homo sapiens (Human) | CMT1A duplicated region transcript 15 protein-like protein; | |
| P11049 (CD37_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Leukocyte antigen CD37; Tetraspanin-26; CD37; | |
| Q9UPY8 (MARE3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Microtubule-associated protein RP/EB family member 3; EB1 protein family member 3; End-binding protein 3; RP3; | |
| P48023 (TNFL6_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Tumor necrosis factor ligand superfamily member 6; Apoptosis antigen ligand; CD95 ligand; Fas antigen ligand; CD178; Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form; Receptor-binding FasL ectodomain; Soluble Fas ligand; sFasL; ADAM10-processed FasL form; APL; FasL intracellular domain; FasL ICD; SPPL2A-processed FasL form; SPA; | |
| Q9BQI9 (NRIP2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Nuclear receptor-interacting protein 2; | |
| Q96IY1 (NSL1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Kinetochore-associated protein NSL1 homolog; | |
| Q6ISU1 (PTCRA_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Pre T-cell antigen receptor alpha; pT-alpha-TCR; | |
| Q969S2 (NEIL2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Endonuclease 8-like 2; DNA glycosylase/AP lyase Neil2; DNA-(apurinic or apyrimidinic site) lyase Neil2; Endonuclease VIII-like 2; Nei homolog 2; Nei-like protein 2; | |
| Q8IZU1 (FAM9A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein FAM9A; | |
| Q6ZMR3 (LDH6A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | L-lactate dehydrogenase A-like 6A; | |
| P16260 (GDC_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Mitochondrial coenzyme A transporter SLC25A16; Graves disease autoantigen; Graves disease carrier protein; Graves' didease protein; Mitochondrial solute carrier protein homolog; Solute carrier family 25 member 16; | |
| Q9UBM4 (OPT_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Opticin; Oculoglycan; | |
| Q06136 (KDSR_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 3-ketodihydrosphingosine reductase; 3-dehydrosphinganine reductase; Follicular variant translocation protein 1; Short chain dehydrogenase/reductase family 35C member 1; | |
| Q53FA7 (QORX_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Quinone oxidoreductase PIG3; NADPH:quinone reductase PIG3; Tumor protein p53-inducible protein 3; p53-induced gene 3 protein; | |
| Q96T54 (KCNKH_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Potassium channel subfamily K member 17; 2P domain potassium channel Talk-2; Acid-sensitive potassium channel protein TASK-4; TWIK-related acid-sensitive K(+) channel 4; TWIK-related alkaline pH-activated K(+) channel 2; | |
| Q99729 (ROAA_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Heterogeneous nuclear ribonucleoprotein A/B; APOBEC1-binding protein 1; | |
| Q9Y2V0 (CDIN1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | CDAN1-interacting nuclease 1; Protein HH114; |
Homo sapiens (Latin: "wise man") is the species name for humans. Believed to have originated in Africa, Homo sapiens is the only surviving member of the Homo genus.
The first complete draft of the human genome was completed in 2001 with an estimated cost of $300million. With the advances in DNA sequencing methods, this price has dropped dramatically down to almost $1000 per genome. By combining the individual genome information with other data, such as protein structure models, personalised medicine becomes viable.
From left to right: i) The number of proteins in the reference proteome of Homo sapiens, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Homo sapiens for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Homo sapiens, please visit Proteome.
You can easily download the latest protein sequences for Homo sapiens proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2026_01 that was used for the most up to date SWISS-MODEL Repository.
| Proteins in proteome | Sequences modelled | Models |
| 20,659 | 17,744 | 43,006 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Homo sapiens reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Homo sapiens proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
| Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 11-mer | 12-mer | 13-mer | 14-mer | 15-mer | 16-mer | 18-mer | 20-mer | 21-mer | 22-mer | 24-mer | 25-mer | 26-mer | 30-mer | 32-mer | 33-mer | 34-mer | 36-mer | 39-mer | 40-mer | 44-mer | 48-mer | 51-mer | 56-mer | 60-mer | 62-mer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38,375 | 3,245 | 320 | 618 | 60 | 138 | 15 | 59 | 2 | 24 | 8 | 45 | 1 | 5 | 2 | 22 | 8 | 1 | 1 | 2 | 15 | 2 | 2 | 1 | 3 | 1 | 1 | 2 | 1 | 7 | 1 | 4 | 1 | 1 | 11 | 2 |